Global Generic Drugs Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,950	176 Pages	QualiKet Research	February, 2022	QUA17148668

Best Price Guarantee
Price	from $3,950
Length	176 Pages
Publisher	QualiKet Research
Published Date	February, 2022
SKU	QUA17148668

Global Generic Drugs Market

Global Generic Drugs Market Size, Trends & Growth Opportunity, By Product Type (Simple Generics, Super Generics, and Biosimilars), By Application (Anti-infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Respiratory Products, Anti-Cancer Drugs, and Others), By Distribution Channel (Pharmacies, Private Clinics, Drug Stores, Hospitals, Retail Pharmacies, and Others), By Region and Forecast till 2027

Global Generic Drugs Market

The generic drugs are defined as the medications which have the same active ingredient as that of branded drugs. They also yield the same therapeutic effect and are prescribed in the same dosing. The inactive ingredients are differ as compared to their branded counter parts. Generic drugs are mainly marketed after a patent expiry of the branded drug. These drugs are of equivalent quality as compared to the branded drugs & are manufactured under the same safety and manufacturing procedures.

Market Drivers

The growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases etc., which expected to boost the global generic drugs market growth over the forecast period. The generic drugs are cheaper & equivalent to barded drugs in strength, dosage, route of administration, performance, quality, and application. Also, the increase in geriatric population positively influence the global generic drugs market growth during this forecast period. Furthermore, the increase in healthcare expenditure expected to fuel the market growth. Moreover, huge demand for generic medicine as well as a large number of patents expired branded drugs will propel the global generic drugs market growth. In addition, the growing demand for newer versions of generic drugs, and large numbers of licensing & partnering strategies to launch new products by key vendors will support the market growth in near future.

Market Restraints

Stringent governmental regulations and adverse effects associated with drugs are anticipated to hamper the global generic drugs market during this forecast timeframe.

Market Segmentation

The Global generic Drugs Market is segmented into product type such as Simple Generics, Super Generics, and Biosimilars, by application such as Anti-infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Respiratory Products, Anti-Cancer Drugs, and Others. Further, market is segmented into distribution channel such as Pharmacies, Private Clinics, Drug Stores, Hospitals, Retail Pharmacies, and Others.

Also, the Global Generic Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are discussed in this report such as Abbott Laboratories, GlaxoSmithKline Plc., Eli Lilly and Company, Pfizer Inc, STADA Arzneimittel AG, Teva Pharmaceutical, Mylan N.V., Sandoz International, Baxter International, ALLERGAN, etc.

Market Taxonomy

By Product Type

Simple Generics
Super Generics
Biosimilars

By Application

Anti-infective Drugs
Anti-Arthritis Drugs
Central Nervous System Drugs
Respiratory Products
Anti-Cancer Drugs
Others

By Distribution Channel

Pharmacies
Private Clinics
Drug Stores
Hospitals
Retail Pharmacies
Others

By Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Key Questions Addressed by the Report

What are the Key Opportunities in Global Generic Drugs Market?
What will be the growth rate from 2019 to 2027?
Which segment/region will have highest growth?
What are the factors that will impact/drive the Market?
What is the competitive Landscape in the Industry?
What is the role of key players in the value chain?
What are the strategies adopted by key players?

1 Introduction: 1.1 Objective of the Study; 1.2 Market definition; 1.3 Market Scope
2 Research Methodology: 2.1 Data Mining; 2.2 Validation; 2.3 Primary Interviews; 2.4 List of Data Sources
3 Executive Summary
4 Global Generic Drugs Market Outlook: 4.1 Overview; 4.2 Market Dynamics; 4.2.1 Drivers; 4.2.2 Restraints; 4.2.3 Opportunities; 4.3 Porters Five Force Model; 4.4 Value Chain Analysis
5 Global Generic Drugs Market, By Product Type: 5.1 Y-o-Y Growth Comparison, By Product Type; 5.2 Global Generic Drugs Market Share Analysis, By Product Type; 5.3 Global Generic Drugs Market Size and Forecast, By Product Type; 5.3.1 Simple Generics; 5.3.2 Super Generics; 5.3.3 Biosimilars
6 Global Generic Drugs Market, By Application: 6.1 Y-o-Y Growth Comparison, By Application; 6.2 Global Generic Drugs Market Share Analysis, By Application; 6.3 Global Generic Drugs Market Size and Forecast, By Application; 6.3.1 Anti-infective Drugs; 6.3.2 Anti-Arthritis Drugs; 6.3.3 Central Nervous System Drugs; 6.3.4 Respiratory Products; 6.3.5 Anti-Cancer Drugs; 6.3.6 Others
7 Global Generic Drugs Market, By Distribution Channel: 7.1 Y-o-Y Growth Comparison, By Distribution Channel; 7.2 Global Generic Drugs Market Share Analysis, By Distribution Channel; 7.3 Global Generic Drugs Market Size and Forecast, By Distribution Channel; 7.3. 1 Pharmacies; 7.3.2 Private Clinics; 7.3.3 Drug Stores; 7.3.4 Hospitals; 7.3.5 Retail Pharmacies; 7.3.6 Others
8 Global Generic Drugs Market, By Region: 8.1 Global Generic Drugs Market Share Analysis, By Region; 8.2 Global Generic Drugs Market Share Analysis, By Region; 8.3 Global Generic Drugs Market Size and Forecast, By Region
9 North America Generic Drugs Market Analysis and Forecast (2020-2027): 9.1 Introduction; 9.2 North America Generic Drugs Market Share Analysis, By Product Type; 9.3 North America Generic Drugs Market Size and Forecast, By Application; 9.4 North America Generic Drugs Market Size and Forecast, By Distribution Channel; 9.5 North America Generic Drugs Market Size and Forecast, By Country; 9.5.1 U.S.; 9.5.2 Canada; 9.5.3 Mexico
10 EuropeGeneric Drugs Market Analysis and Forecast (2020-2027): 10.1 Introduction; 10.2 Europe Generic Drugs Market Share Analysis, By Product Type; 10.3 Europe Generic Drugs Market Size and Forecast, By Application; 10.4 Europe Generic Drugs Market Size and Forecast, By Distribution Channel; 10.5 Europe Generic Drugs Market Size and Forecast, By Country; 10.5.1 Germany; 10.5.2 France; 10.5.3 UK; 10.54. Rest of Europe
11 Asia Pacific Generic Drugs Market Analysis and Forecast (2020-2027): 11.1 Introduction; 11.2 Asia Pacific Generic Drugs Market Share Analysis, By Product Type; 11.3 Asia Pacific Generic Drugs Market Size and Forecast, By Application; 11.4 Asia Pacific Generic Drugs Market Size and Forecast, By Distribution Channel; 11.5 Asia Pacific Generic Drugs Market Size and Forecast, By Country; 11.5.1 China; 11.5.2 Japan; 11.5.3 India; 11.5.4. Rest of Asia Pacific
12 Latin America Generic Drugs Market Analysis and Forecast (2020-2027): 12.1 Introduction; 12.2 Latin America Generic Drugs Market Share Analysis, By Product Type; 12.3 Latin America Generic Drugs Market Size and Forecast, By Application; 12.4 Latin America Generic Drugs Market Size and Forecast, By Distribution Channel; 12.5 Latin America Generic Drugs Market Size and Forecast, Country
13 Middle East Generic Drugs Market Analysis and Forecast (2020-2027): 13.1 Introduction; 13.2 Middle East Generic Drugs Market Share Analysis, By Product Type; 13.3 Middle East Generic Drugs Market Size and Forecast, By Application; 13.4 Middle East Generic Drugs Market Size and Forecast, By Distribution Channel; 13.5 Middle East Generic Drugs Market Size and Forecast, By Country
14 Competitive Analysis: 14.1 Competition Dashboard; 14.2 Market share Analysis of Top Vendors; 14.3 Key Development Strategies
15 Company Profiles: 15.1 Abbott Laboratories; 15.1.1 Overview; 15.1.2 Offerings; 15.1.3 Key Financials; 15.1.4 Business Segment & Geographic Overview; 15.1.5 Key Market Developments; 15.1.6 Key Strategies; 15.2. GlaxoSmithKline Plc.; 15.2.1 Overview; 15.2.2 Offerings; 15.2.3 Key Financials; 15.2.4 Business Segment & Geographic Overview; 15.2.5 Key Market Developments; 15.2.6 Key Strategies; 15.3. Eli Lilly and Company; 15.3.1 Overview; 15.3.2 Offerings; 15.3.3 Key Financials; 15.3.4 Business Segment & Geographic Overview; 15.3.5 Key Market Developments; 15.3.6 Key Strategies; 15.4 Pfizer Inc; 15.4.1 Overview; 15.4.2 Offerings; 15.4.3 Key Financials; 15.4.4 Business Segment & Geographic Overview; 15.4.5 Key Market Developments; 15.4.6 Key Strategies; 15.5 STADA Arzneimittel AG; 15.5.1 Overview; 15.5.2 Offerings; 15.5.3 Key Financials; 15.5.4 Business Segment & Geographic Overview; 15.5.5 Key Market Developments; 15.5.6 Key Strategies; 15.6 Teva Pharmaceutical; 15.6.1 Overview; 15.6.2 Offerings; 15.6.3 Key Financials; 15.6.4 Business Segment & Geographic Overview; 15.6.5 Key Market Developments; 15.6.6 Key Strategies; 15.7 Mylan N.V.; 15.7.1 Overview; 15.7.2 Offerings; 15.7.3 Key Financials; 15.7.4 Business Segment & Geographic Overview; 15.7.5 Key Market Developments; 15.7.6 Key Strategies; 15.8 Sandoz International; 15.8.1 Overview; 15.8.2 Offerings; 15.8.3 Key Financials; 15.8.4 Business Segment & Geographic Overview; 15.8.5 Key Market Developments; 15.8.6 Key Strategies; 15.9 Baxter International; 15.9.1 Overview; 15.9.2 Offerings; 15.9.3 Key Financials; 15.9.4 Business Segment & Geographic Overview; 15.9.5 Key Market Developments; 15.9.6 Key Strategies; 15.10 ALLERGAN; 15.10.1 Overview; 15.10.2 Offerings; 15.10.3 Key Financials; 15.10.4 Business Segment & Geographic Overview; 15.10.5 Key Market Developments; 15.10.6 Key Strategies